RUBINSTEIN ALAN I has a total of 19 patent applications. Its first patent ever was published in 1987. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are NAT INSTITUTE OF IMMUNOLOGY, VIREXX MEDICAL CORP and UNIV HOSPITALS CLEVELAND MEDICAL CT.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 3 | |
#4 | Canada | 2 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Environmental technology | |
#5 | Foods and drinks | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Object sterilising | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Diagnosis and surgery | |
#6 | Climate change adaptation technologies | |
#7 | Food proteins | |
#8 | Unspecified technologies | |
#9 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rubinstein Alan I | 18 |
#2 | Rubinstein Daniel B | 3 |
#3 | Olah Andrew M | 1 |
#4 | Olah Emery | 1 |
#5 | Rubinstein Alan | 1 |
Publication | Filing date | Title |
---|---|---|
AU5767400A | Bone marrow biopsy needle | |
AU4156096A | Non-infective vaccines | |
US5595186A | Bone marrow biopsy needle | |
US5281392A | Method for disinfecting red blood cells, blood products, and corneas | |
AU2251288A | Sequential improved method for treatment of human blood- clotting factor products | |
EP0445108A4 | A method for treating gammaglobulin | |
EP0315627A1 | A method to treat blood. |